Stikeman Elliott LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Stikeman Elliott LLP advises pharmaceutical, biotech, medical devices, biomedical technologies and other life sciences sectors on business issues and corporate transactions. It has assisted clients with product and establishment licensing, pricing and reimbursement strategies, market access and clinical trials. On the corporate side is represents clients in mergers and acquisitions, venture capital and growth capital transactions as well as research and development grants. Dee Rajpal and Sara Zborovski co-lead the Toronto team, Rajpal assists with a slew of corporate transactions, while Zborovski is experienced in handling regulatory and compliance matters related to the Food and Drugs Act and the Controlled Drugs and Substances Act.
Legal 500 Editorial commentary
Key clients
- Corealis Pharma
- Jamp Pharma